Mustang Bio (MBIO) Research & Development (2016 - 2026)

Mustang Bio (MBIO) has reported Research & Development for 11 consecutive years, with $224000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 128.57% year-over-year to $224000.0 in Q2 2026; TTM through Jun 2026 was -$248000.0, a 59.48% increase from a year earlier, with the FY2025 full-year figure at -$1.5 million, down 118.01% from the prior year.
• Research & Development was $224000.0 for Q2 2026 at Mustang Bio, up from $178000.0 in the prior quarter.
• Over five years, Research & Development peaked at $16.3 million in Q1 2022 and troughed at -$964000.0 in Q1 2025.
• A 5-year average of $6.1 million and a median of $4.1 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development tumbled 684.21% in 2025 and soared 128.57% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $15.6 million in 2022, then tumbled by 60.58% to $6.1 million in 2023, then sank by 96.8% to $197000.0 in 2024, then slumped by 260.91% to -$317000.0 in 2025, then jumped by 170.66% to $224000.0 in 2026.
• The last three Research & Development figures came in at $224000.0 (Q2 2026), $178000.0 (Q1 2026), and -$317000.0 (Q4 2025), per Business Quant data.